The SpaceX IPO Is Closer Than You Think. These Are the Stocks That Win When It Happens.

Rocket Lab has launched 88 rockets to date and is expanding into orbital and spacecraft manufacturing services, while AST SpaceMobile plans 45 to 60 satellites in orbit by end-2026 and as many as 248 within a few years. Analysts expect Rocket Lab revenue to more than double from 2025 to 2028, versus AST revenue surging more than 26 times, which supports a constructive long-term view. The article is bullish on both names relative to SpaceX, but it is largely commentary rather than new company-specific news.

Analysis

The cleaner read-through is not “space is hot,” but that capital is rotating toward the most credible toll collectors on two different layers of the stack: launch cadence for RKLB and network-density optionality for ASTS. That matters because both names are still at the stage where execution deltas re-rate the equity more than end-market TAM; small changes in launch reliability or satellite deployment pace can drive outsized multiple expansion or compression over the next 2-6 quarters.

RKLB’s real opportunity is that launch is becoming a gateway product, not the profit pool. As the mix shifts toward spacecraft manufacturing and mission services, the market should start valuing backlog quality and margin mix more than headline launch count. The risk is that investors extrapolate cadence gains too aggressively and miss the fact that any launch anomaly or supply-chain bottleneck would hit confidence immediately, even if long-run demand remains intact.

ASTS is more binary but also more levered to a second-order network effect: every additional satellite improves serviceability, which improves carrier willingness to commit, which then lowers financing risk and raises the probability of a self-funding capital path. The consensus may be underestimating dilution risk and timing risk on commercialization; the stock can work dramatically if deployment milestones are hit, but the path likely remains financing-sensitive for multiple quarters. In other words, ASTS is a milestone trade, not a straight-line growth compounder.

The contrarian angle is that this is less a pure “buy the space theme” and more a relative-value call on execution credibility versus hype. SpaceX’s IPO may inflate sector enthusiasm, but the beneficiaries with the best risk/reward are the listed names where the market can still misprice progress because they’re smaller and less institutionally owned. That creates opportunity, but only if investors size for dispersion rather than theme beta.

Key Decisions for Investors

• Go long RKLB on pullbacks over the next 1-3 weeks, with a 3-6 month horizon; upside is continuation of multiple expansion if launch cadence translates into higher-margin services mix, while downside is sharp on any execution miss or delayed mission.
• Use ASTS as a smaller-size core long only if you can tolerate financing volatility; prefer staged entries ahead of catalyst windows, because the stock should outperform into deployment milestones but can give back gains quickly if capital raises are needed.
• Pair trade: long RKLB / short a weaker space or early-stage hardware peer on relative execution, aiming for 10-20% spread capture over 2-4 quarters if cadence and backlog conversion continue to improve.
• For higher-risk accounts, buy medium-dated call spreads on RKLB rather than outright stock to express upside from sentiment spillover while limiting damage from launch or supply-chain setbacks.
• Treat ASTS as a catalyst-driven trade, not an investment-grade growth long until financing visibility improves; trim or hedge into sharp run-ups ahead of known orbital-deployment milestones.